Want to join the conversation?
$TMO said it completed the acquisition of Affymetrix at the end of March 2016 for $1.3Bil. Affymetrix is now part of the the Life Sciences Solutions segment. The company expects to generate $70MM of operating income synergies by year three following the close, $55MM from cost and $15MM from revenue.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?